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Many fundamental questions regarding immunobiological reactions 
are  as  yet unanswered.  However, certain working principles  have 
been reached through long observation and research, and the terms 
foreign protein  reactions,  complement,  precipitins,  antibodies,  ana- 
phylaxis,  etc.,  have acquired definite and specific  significance.  At- 
tempts  have been made to fit these concepts to  clinically observed 
phenomena, but to date the so called pollen sensitizations have never 
been satisfactorily elucidated on an immunological basis.  Many ob- 
servers  have  noted  the  wide  variations  in  the  clinical  results  of 
therapy.  Others have questioned the expectation of any significant 
effects from the injection of so little real  protein  in  desensitization 
and have found it difficult to correlate this desensitization and clini- 
cal improvement with a skin test persistently positive to the specific 
atopic agent.  The apparent inability to obliterate these  hypersen- 
sitivities, as well as their frequent multiplicity are problems  as  yet 
unexplained. 
Efforts  at  solving  these  problems  have  resolved themselves into 
(a)  attempts  to  sensitize animals  and  reproduce the syndrome ob- 
served in human beings  (1);  (b)  the study of Dale preparations  of 
uterine  strips  taken  from  sensitized guinea pigs  (2);  (c)  efforts  to 
sensitize animals by upper air passage or intratracheal insufftation (1); 
(d) the investigation of serum reagins by Prausnitz-Kfistner reaction 
and by precipitin tests (3);  (e) studies of results of therapy in clinical 
cases of atopic hypersensitiveness (4).  These investigations are well 
known to readers of the literature on the subject.  As with all  bio- 
logical experiments the results have been inconstant, or the methods 
introduced elements into the problem not germane to the investigation 
at hand. 
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These  and many other considerations led us  to  inquire  into  the 
possible  mechanisms  involved.  What  substances  in  the  realm  of 
immunological reagents might reproduce such a series of phenomena? 
Landsteiner and van der  Scheer (5),  Avery and  Goebel (6,  7),  and 
others, following Landsteiner's original hapten concept, investigated 
the properties of certain synthesized antigens.  They found that the 
antigen was essentially dual in structure, a  larger portion possessing 
antigenicity, and  a  smaller, prosthetic portion  (hapten),  specificity. 
The union between these two was not close; there was either a loose 
chemical bond,  or  a  simple  colloidochemical linkage.  The  specific 
hapten portion, when united with either antigenic nucleus (or hapto- 
phore  group),  was  capable  of  calling  forth  the  specific  response, 
whereas the hapten portion alone, while it could elicit a positive skin 
reaction  (e.g.  the  pneumococcus specific soluble  carbohydrate),  ac- 
tually inhibited the union of antigen and antibody in vitro. 
It is possible that the mechanism involved in atopic hypersensitivity 
represents  just  such  a  hapten-like  action,  rather  than  the  tacitly 
assumed, firmer union of true antigen-antibody complex.  Certainly 
atopens as a  rule are protein-poor substances;  they elicit cutaneous 
evidence of sensitivity, but in general are ineffective in calling out 
demonstrable  precipitins.  However,  they  give  a  positive  passive 
transfer  phenomenon.  Landsteiner  has  shown  that  these  haptens 
may be  carbohydrates, lipoids, or  relatively much smaller proteins. 
Does  some such  non-specific antigen produce  the  allergic state  re- 
ferred to as underlying sensitivity, or antibody unsaturation, or proto- 
plasmic instability (8)?  Or shall we be content to accept it as some 
change  (Kahn  (9))  which is  "rooted  in  the  biologic  and  physico- 
chemical structure of the chromosomes"? 
It was felt that an experiment might be planned which would throw 
some light on a  few of these questions.  Various proteins were em- 
ployed as basic sensitizers, always using a  1:25  extract  of  burweed 
marsh-elder  (Ira)  as  the  superimposed  atopen.  Experiments  were 
done on several series of guinea pigs: one with veal broth; two with egg 
white; and one (the present), with horse serum.  This last was found 
to give the most consistent and dear-cut results.  We report in detail 
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Materials and Method 
The guinea pigs were all males, weighing  between 300  and 500  gm.  Injec- 
tions, with Luer syringes and ~  inch, 26 gauge needles, were made intracutane- 
ously with some possible subcutaneous leakage.  All injections were 0.4 cc.  in 
quantity. 
Normal horse serum was obtained from Eli Lilly Co.; the extract of burweed 
marsh-elder (Ira xanthifolia) was made in our laboratory as follows: 
The following solvent was prepared: 
KH~PO4 .............................................  0.54 gm. 
Na~HP04 ...........................................  2.26 gin. 
NaCI ...............................................  9.00 gin. 
Phenol ..............................................  2.5  gin. 
Glucose  .............................................  25.0  gin. 
Water, sufficient to make ..............................  500.0  cc. 
To each 100 co. of solvent was added 4 gin. of clean pollen (1931).  The mix- 
ture  was  shaken  for  24  hours,  centrifuged,  and  the  supernatant  fluid filtered 
through standard, fine filter paper.  This was next filtered through a  Seitz filter 
and tested for bacterial growth; found sterile, it was kept on ice when not in use. 
The mixture of equal volumes of horse serum and  pollen extract was allowed 
to stand at room  temperature for 24 hours; at various times during the 3 weeks 
previous to use it was taken from the ice box for repeated room  temperature ex- 
posures.  The mixture produced no precipitate. 
Throughout  the  experiment separate syringes were  used  for each  material. 
These were recorded by their serial numbers etched on the barrel and plunger, 
and  their  identities  constantly  maintained.  After  use  they  were  cleaned 
separately. 
Quantitative analysis (Kjeldahl) of the horse serum showed it to contain 7.35 
gln.  per  cent  protein.  Average determinations of protein content  of  the Ira 
extract yielded about 50 rag. per cent.  In the latter there were wide variations, 
due either to  the batch, of extract, or the method of analysis. 
3  weeks after the  final sensitizing injections blood samples were  drawn  by 
venipuncture for precipitin titration with Ira and horse serum, and shock experi- 
ments done with both of these substances.  For this the jugular vein was ex- 
posed, blood first taken by syringe, and 0.4 cc. of the shocking material slowly 
injected.  Each animal was observed for a  minimum of  1 hour following this 
procedure, and the reactions carefully recorded. 
EXPERIMENTAL 
Six guinea pigs  were sensitized  by three  injections  (0.4  cc. each) of whole 
horse serum at in~tervals  of 4 days.  After 3 weeks these (Group B0) and six 
normal  guinea pigs  (Group B) were  given three  injections  (0.4  cc.  each)  of  pollen 152  ANAPHYLAXIS  WITH  POLLEN 
extract  (Ira xantkifolia),  at 4 day intervals.  At the same time twelve  normal 
guinea pigs were injected with three inoculations (0.4 cc.) of equal parts of horse 
serum and pollen extract (Group A), and a fourth group (Group C) of six animals 
were sensitized by injections of horse serum alone (0.4 cc.).  3 weeks after the 
final inoculation the precipitins for pollen extract and for horse serum were in- 
vestigated,  and the anaphylactic  response to these  substances  studied.  These 
are set forth in Table I. 
As shown in the table, marked  differences were obtained  between 
the several groups of animals,  most notably in their  response  to the 
test of anaphylaxis.  All the guinea pigs of Groups A  and  B0 which 
had  received  both  horse  serum  and  pollen,  reacted  to  intravenous 
pollen  extract  with moderate to  severe anaphylaxis.  One  such  ani- 
mal, No. 1-3, was shocked fatally (4+), and only one, No. 1-2,  showed 
a  negative response, having received only half the regular shock dose 
(or  0.2  cc.). 
In  Group  B  (animals  prepared  with  pollen  extract  alone),  ana- 
phylaxis to pollen extract could not be demonstrated,  even though in 
one instance the intravenous dose was doubled.  It might be pointed 
out that the absolute amount of pollen extract given in the preliminary 
injections in this group  was actually twice that  received by animals 
of Group  A. 
Anaphylaxis to horse serum was almost uniformly severe in Groups 
A,  B0,  and  C.  One animal,  No.  9-1,  showed  only a  mild  reaction. 
Group  B  pigs  were  quite  negative  to  intravenous  horse  serum  on 
several trials,  and  pollen  extract  educed no  response in  the  animals 
sensitive to horse serum alone (Group C). 
The skin tests in all groups of this series were inconclusive.  How- 
ever, in the three previous series, at a similar date the skin reaction to 
pollen  extract  intracutaneously  was  by objective measurement  defi- 
nitely  greater  in  the  Group  A  animals  than  in  those  of  Group  B. 
There were no  Group B0 pigs in the earlier experiments. 
Precipitin tests in all four series were carried out in the manner  de- 
scribed by Hektoen.  The  results  were not sufficiently conclusive to 
permit  any inferences.  They are  reported,  however, as a  matter  of 
possible investigative  interest. 
DISCUSSION 
By means  of  the  above  and  similar  experiments  we  have  shown 
that in the presence of an underlying sensitization, a substance not in TABLE I 
Series IV 
Group A.  Pollen-horse serum, equal parts.' 
Group B.  Pollen extract alone.  0.4 cc. injected Aug. 21, 24, and 29. 
Group C.  Horse serum alone. 
Group B0 received same injections as Group B, but 4 weeks after injections 
of horse serum, 0.4 cc. on July 16, 20, 24. 
Preclpitln test for  Anaphylaxis  to 
Animal  Group  No.  Remarks 
Pollen 
A  1  Neg. 
2  Pos. (wk.) 
3  Pos. 
4  Pos. (+-I-) 
5 
8 
1-2  Pos. 
1-3 
1-4  Pos. (+) 
1-5  Pos. (+) 
1-6  Pos. 
B  1-0 
1-I  Pos. (wk.) 
1-8  Neg. 
2-4 
2-5 








C  1-9 
7-7 
9-6  Neg. 
9-7 
9-8  Pos. (?) 
1-00  Neg. 













































Received  1/~  shock 
dose 
Pos.  Shwartzman 
phenomenon 
t~ + + +  =  lethal, with jactitation, convulsions,  etc. 
Anaphylactic  + + +  =  dyspnea, convulsions,  prostrations with survival. 
response  +  =  dyspnea, cyanosis,  wheezing,  cough, loss of posture. 
ffi cough,  sneeze,  scratching  of  nose,  cyanosis,  slight 
dyspnea, micturition, defecation, nervousness. 
Precipitin test--wk.  --  turbidity only slightly greater than control. 
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itself capable of sensitizing can induce the hypersensitive state, and, 
when properly administered, produce anaphylactic shock.  Hektoen 
(10) and Parker (11) have both done similar experiments but reported 
no tests on the anaphylactic response. 
Rothschild,  Friedenwald, and  Bernstein  (12),  working on  desen- 
sitization of tuberculin-sensitive guinea pigs (sensitized by inoculation 
with avirulent strain of Koch's bacillus), found that Koch's old tuber- 
culin (O.T.) in suitable doses could produce complete desensitization 
by all the criteria they were able to apply.  They found also that the 
broth control produced almost as complete a desensitization, whereas 
a tuberculoprotein (Seibert) of equal skin test potency produced very 
little diminution in sensitivity.  The difference apparently lay in the 
beef protein content of the O.T.  This finding suggests the important 
r61e that non-specific immunological reactions may play in the evolu- 
tion and subsequent course of the allergic state.  In  this  connection 
may be mentioned the frequent improvement noted in patients with 
allergic disease during acute infections, and  following vaccines  and 
non-specific protein therapy. 
How  closely this  experimentally induced condition  approximates 
the  actual  clinicoimmunologic mechanism  can  only  be  surmised. 
Further work along these lines is being undertaken with a  view to 
clinical application. 
SU'M~ARY  AND  CONCLUSIONS 
1.  Guinea pigs injected intracutaneously and subcutaneously with 
extract  of  the  pollen  of  burweed  marsh-elder  in  relatively  small 
amounts did not  show anaphylactic response  to  intravenous  shock 
doses of this material 3 weeks later. 
2.  If, however, the animals were sensitized with horse serum either 
before, or along with the same pollen injections, they could then be 
shocked after an interval of 3 weeks with pollen extract alone. 
3.  The possible  r61e of this  underlying sensitivity is  discussed. 
The author wishes to express his appreciation of the helpful criticism 
given by Dr. O. H. P,  obertson. 
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